Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-19
    E.g., 2018-02-19



62 items
3:07 PM, Feb 08, 2018  |  BC Innovations | Finance

External rethink

As the industry seeks to develop new ways to access external innovation, companies are re-evaluating the value of public-private partnerships, and increasingly turning to other companies for research partnerships in lieu of broad deals with...
1:20 PM, Nov 09, 2017  |  BC Innovations | Finance

The return of big

After a slow second quarter, pharmas have stepped up their activity in public-private partnerships, announcing 13 in 3Q17, compared with only five in the quarter before. The deals bring the third quarter total to 56,...
4:51 PM, Oct 19, 2017  |  BC Innovations | Finance

Broad umbrella

In its $50 million tie-up with the Broad Institute of MIT and Harvard, Deerfield Management is looking to forge a new mold of partnership with an academic organization that allows it to efficiently survey early...
12:55 PM, Oct 12, 2017  |  BC Innovations | Finance

IRDiRC dreams bigger

After presiding over rapid growth in the global effort to diagnose and treat rare diseases over the past six years, the International Rare Diseases Research Consortium (IRDiRC) announced three new goals, one of which is...
1:56 PM, Aug 17, 2017  |  BC Innovations | Finance

Built to purpose

With almost 40 start-ups engaging in build-to-buy deals since 2013 and an average 2-4 years for up or down decisions, the next year could see a spate of acquisitions -- or options declined -- that...
6:41 PM, Aug 10, 2017  |  BC Innovations | Finance

2Q17 public-private partnership update

The appetite for forming new multi-party consortia continued to cool this quarter, accounting for the lowest number of new PPPs in 1H17 since 2011. Only 3 consortia -- defined by BioCentury as public-private partnerships (PPPs) with...
3:38 PM, Jul 20, 2017  |  BC Innovations | Finance

Sharpless edge for NCI

The National Cancer Institute is poised to enter a new phase, under the leadership of Norman (Ned) Sharpless, following the June 9 announcement by the White House of the president’s choice to fill the large...
3:30 PM, Jun 08, 2017  |  BC Innovations | Finance

The bio-tech bridge

Last year’s flurry of interest from tech titans has brought a wealth of new funding to translational science that is gaining them status as new and important players in the biotech ecosystem. With a heavy...
1:15 PM, May 25, 2017  |  BC Innovations | Finance

Europe’s translational springtime

European science is showing early signs of translational growth, with VCs increasingly shifting their focus to preclinical assets. But investors are concerned the region still doesn’t have the supply of management talent or funding it...
6:01 PM, Apr 27, 2017  |  BC Innovations | Finance

1Q17 public-private partnership roundup

This quarter’s deal-making in public-private partnerships (PPPs) picked up from the slow rate in the second half of last year, with 1Q17 activity comparable to that seen at the start of last year. Led by...